Treatment of scleroderma skin ulcers using becaplermin gel and hydrocolloid membrane.

@article{Yoon2002TreatmentOS,
  title={Treatment of scleroderma skin ulcers using becaplermin gel and hydrocolloid membrane.},
  author={Jerry Yoon and J. Giacopelli and D. Granoff and Wesley Kobayashi},
  journal={Journal of the American Podiatric Medical Association},
  year={2002},
  volume={92 6},
  pages={
          350-4
        }
}
Skin ulcers can be very painful and detrimental in patients with systemic sclerosis, or systemic scleroderma. A brief review of scleroderma skin ulcers is presented, as well as a case study that demonstrates the effectiveness of becaplermin gel supplemented by oral immunosuppressive agents in the treatment of ulcers resulting from systemic sclerosis. The time to healing (approximately 3 months) was comparable to that associated with the oral agents and surgical interventions specifically… Expand
Platelet gel in the treatment of severe scleroderma skin ulcers
TLDR
Platelet gel (PG) may represent a novel therapeutic option for SSc skin ulcers refractory to conventional treatments and patient’s quality of life markedly improved. Expand
Use of Equine Derived Pericardium as a Biological Cover To Promote Closure of a Complicated Wound With Associated Scleroderma and Raynaud's Disease .
TLDR
A 39-year-old man with previously undiagnosed scleroderma was admitted to the UCSD Medical Center with bilateral, limb-threatening necrotic lower extremity ulcers extending to underlying fascia and muscle and underwent extensive tissue debridement followed by placement of an equine pericardium xenograft. Expand
Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma)
TLDR
A single case of a scleroderma patient whose pain of digital ulcers could be successfully managed by an application of topical lidocaine is reported, and the patient was highly satisfied with the dramatic improvement in her pain. Expand
Therapeutic Options for Digital Ulcers in Patients with Systemic Sclerosis
  • L. Chung
  • Medicine
  • Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
  • 2007
TLDR
Treatments for digital ulcers arise from recurrent ischemic injury and microtrauma, and include non‐pharmacologic modalities such as avoiding cold, stress, and trauma, as well as smoking cessation. Expand
The skin in autoimmune diseases-Unmet needs.
TLDR
There is a high unmet need for new therapeutic strategies focusing on skin involvement in systemic autoimmune diseases, and innovative designs of randomized controlled trials with validated skin scores are warranted to develop new therapeutic Strategies for patients with cutaneous manifestations. Expand
[Becaplermin gel (Regranex gel)].
  • P. Senet
  • Medicine
  • Annales de dermatologie et de venereologie
  • 2004
TLDR
Topical application of rhPDGF-BB speeds wound healing and promotes granulation tIssue formation, synthesis of extracellular matrix and the inflammatory phase of the wound healing process in healthy and healing-impaired animal models. Expand
Accelerated healing of cutaneous wounds using phytochemically stabilized gold nanoparticle deposited hydrocolloid membranes.
TLDR
The therapeutic effects of phytochemically stabilized gold nanoparticles coated on a hydrocolloid membrane (HCM) for curing cutaneous wounds are reported and it is probable that the accelerated process of wound healing in the injured skin of SD rats via pAuNP-HCM results from the synergistic regulation of angiogenesis and connective tissue formation, as well as the stimulation of antioxidant effects. Expand
Leg Ulcers of Unusual Causes
TLDR
Cutaneous ulcers due to malignancy of unusual leg ulcers with hematologic disorders, vasculitis, sarcoidosis, calciphylaxis, Buerger’s disease, and pyoderma gangrenosum are discussed. Expand
Measurement of Upper Limb Ulcers in Patients With Systemic Sclerosis: Reproducibility and Correlation With Pain, Function, and Quality of Life
TLDR
Simple measurement instruments for the assessment of ischemic ulcers were reproducible in patients with SSc and correlated to other variables of interest for these wounds. Expand
Therapeutische Optionen für digitale Ulzera bei Patienten mit systemischer Sklerodermie
Einleitung Die systemische Sklerodermie (SS) ist eine Autoimmunkrankheit, die durch Störungen im Bereich der Mikrogefäße und eine Fibrose der Haut und inneren Organen gekennzeichnet ist. NeunzigExpand
...
1
2
...

References

SHOWING 1-10 OF 13 REFERENCES
Treatment of scleroderma skin ulcers with a hydrocolloid membrane.
TLDR
Hydrocolloid membrane treatment of sclerodermatous hand ulcers appears to be an effective method of accelerating healing and reducing pain. Expand
Nifedipine in Scleroderma Ulcerations
TLDR
Nifedipine, a calcium antagonist, has been shown to improve cutaneous blood flow and to alleviate reactive vasospastic ischemia (Raynaud's phenomenon) in patients with cutaneous ulcerations. Expand
Lower limb amputation secondary to large vessel involvement in scleroderma.
A 34-year-old woman with scleroderma was admitted to hospital with pain and weakness of her left foot. She was subsequently shown to have developed a popliteal artery occlusion associated withExpand
Rhythmic external compression of the limbs: a method for healing cutaneous ulcers in systemic sclerosis.
TLDR
Rec could represent a therapeutic option in the treatment of ischemic cutaneous ulcers in SSc and was statistically more frequent in the distal ulcers (fingers and toes), independent of SSc variant. Expand
Successful treatment of an extended leg ulcer in systemic sclerosis.
TLDR
Radical debridement combined with a split skin graft seems to be a promising way to avoid amputation of a large and painful leg ulcer associated with systemic sclerosis. Expand
Treatment of ischaemic digital ulcers and prevention of gangrene with intravenous iloprost in systemic sclerosis.
TLDR
Iloprost appears useful as a treatment of imminent gangrene and ischaemic ulcers in systemic sclerosis and this reparatory capacity could also be of a more general importance in therapy of this disease. Expand
Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study
TLDR
Becaplermin gel 100 μg/g, in conjunction with good wound care, significantly increased the incidence of complete wound closure and significantly reduced the time to complete closure of chronic diabetic neuropathic ulcers. Expand
Electron microscopy and capillaroscopically guided nailfold biopsy in connective tissue diseases: detection of ultrastructural changes of the microcirculatory vessels.
TLDR
Electron microscopic examination of specimens obtained by capillaroscopically guided nailfold biopsy is able to disclose histopathological differences between defined entities, and may be a useful tool to gain further insights into potentially separable aetiopathological mechanisms of the various types of CTD. Expand
Preclinical promise of becaplermin (rhPDGF-BB) in wound healing.
TLDR
The objective of this article is to review how the study of rhPDGF-BB in animal wound healing models has assisted in addressing the potential clinical utility of rhPSB-BB. Expand
The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
TLDR
Patients with SSc are in a hypercoagulable state characterized by elevated plasma levels of FNG and vWF, by a dual hypofibrinolytic pattern (defective tPA release and elevated PAI), and by increased thrombin generation with enhanced fibrin formation. Expand
...
1
2
...